We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 24 Jun 2021
Print article
Image: BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021 (Photo courtesy of Becton, Dickinson and Company)
Image: BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021 (Photo courtesy of Becton, Dickinson and Company)
Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) demonstrated its latest Medtech innovations at Medlab Middle East 2021 focusing on infection prevention and control, integrated diagnostics, and lab automation.

At this year’s Medlab Middle East, the company showcased its rapid diagnostic testing solutions to enable caregivers perform high number of tests in a short duration of time; advanced informatics and integrated diagnostics to enhance testing, automate workflows and help expedite decision-making; cutting-edge solutions for microbiology testing to facilitate rapid implementation of infection prevention and control measures; as well as microbiology automation amongst others. Experts from the BD team were also present at the company’s booth to host various in-depth sessions, share best practices, and demonstrate an array of innovative solutions to tackle the region’s ongoing healthcare challenges.

“Last year, the world was exposed to undesirable medical extremities,” said Maher Elhassan, Vice President & General Manager, BD Middle East, North Africa & Turkey. “Now is the time when communities in the region and throughout the world need our continued support and expertise to be able to fight all adversaries and recover. As part of our mission to advance the world of health, BD is determined to leave no stone unturned in our quest to impact people’s lives. Our participation at Medlab Middle East reiterates the company’s efforts to support the region’s healthcare sector with our latest innovations that deliver on patient care, safety, diagnostic accuracy, automation and more.”

Related Links:
Becton, Dickinson and Company

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Saliva Collection & Stabilization Device
Salicomb/Saliswab
New
RFID Inlay
Minidose U8 RAIN

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.